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Similarity of Chemokines Charge and
the V3 Domain of HIV-1 env Protein
To the Editor: Most clinical HIV-1 isolates can
infect CD4+ peripheral blood T lymphocytes,
monocytes, and cultured macrophages (macroph-
age or M-tropic) but not transformed T-cell lines.
In contrast, HIV-1 strains adapted for growth in
transformed T-cell lines (T-cell line or T-tropic)
do not infect primary monocytes or macrophages.
This difference in tropism appears to be a
consequence of specific amino acid changes in the
env protein. Changes in env responsible for an M-
to T-tropism shift often involve the acquisition of
multiple positively charged residues in the
hypervariable V3 loop domain (1). However, some
non-V3 determinants are also important for viral
tropism. Although both types of viruses use CD4
as receptor, the CXCR4 chemokine receptor
(previously designated LESTR/fusin) is the
unique cofactor for entry of T-tropic HIV-1
strains (2). The CCR5 chemokine receptor was
subsequently demonstrated to be the cofactor for
M-tropic HIV-1 isolates (3). Although some direct
evidence for cell surface association of the CD4-
env complex and the CXCR4 coreceptor was
obtained (4), little detail is available on the
molecular forces responsible for these protein-
protein interactions. In particular, there is no
direct evidence to indicate that the V3 loop binds
to the chemokine receptor.
Jiang (5) reported that the extracellular
domain of the CXCR4 coreceptor for T-tropic
HIV-1 isolates is more negatively charged than
the CCR5 coreceptor. Because T-tropic isolates
have evolved a positively charged V3 domain, it
was suggested that coreceptor-env binding
involves the interaction between oppositely
charged residues. We now expand this analysis
by showing that the chemokines corresponding to
the different receptors have a similarly unbal-
anced composition of charged amino acids. So far,
the CXCR4 receptor has been demonstrated to
bind only the SDF-1 chemokine (6). The CCR5
receptor binds more than one chemokine,
including RANTES, MIP-1a , and MIP-1ß (7). The
amino acid sequence of these four chemokines is
presented in the Figure. We listed the number of
positive residues (arginine [R] and lysine [K]) and
negative residues (aspartic acid [D] and glutamic
acid [E]), and calculated the net charge. SDF-1
appears to have the highest number of positive
residues and the lowest number of negative
residues, resulting in a net charge of +11. All
other chemokines have much less positively
charged amino acids, resulting in a net charge for
MIP-1a and MIP-1ß of -2 and -1, respectively. The
RANTES chemokine has an intermediate charge
of +7, which may correlate with the unique
receptor use of this chemokine (e.g., RANTES,
but not MIP-1a and MIP-1ß, binds the CCR3
receptor [7]). These results are consistent with
the idea that positive charges in SDF-1 interact
with negative charges in the CXCR4 receptor,
and this binding may thus resemble the HIV-1
env-CXCR4 interaction.
Early evidence that both the chemokines and
HIV-1 bind to the same domain of the chemokine
receptor comes from virus inhibition studies.
Several ß-chemokines suppress infection with M-
tropic but not T-tropic HIV isolates (8), and SDF-
1 specifically blocks entry of T-tropic isolates (6).
Although direct blocking of the receptor may
explain part of this chemokine-mediated inhibi-
tion, it has also been proposed that internaliza-
tion of the receptor contributes to the antiviral
effect (9). Irrespective of the precise antiviral
mechanism, the combined results of this analysis
Figure. Amino acid alignment of the four chemokines was performed with the PC/Gene program. An overall identity and
similarity of 12.4% and 40.2% was calculated, respectively. The initiator methionine contained within each sequence is re-
moved in the processing of the chemokine. The SDF-1 form shown is the ß-form; the a -form lacks the C-terminal amino acids
RFKM, thus reducing the net charge to +9.
* = a perfectly conserved residue.
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and the one presented by Jiang (5) suggest that
both the SDF-1 chemokine and the V3 loop of T-
tropic HIV-1 viruses use positively charged
amino acids for an electrostatic interaction with
the negatively charged CXCR4 receptor. To
examine whether the similarity between the
chemokine and env V3 domain is also apparent at
the primary sequence level, we performed an
amino acid alignment; however, we found no
conserved motifs (data not shown). A detailed
mutational analysis is required to further our
understanding of the env-coreceptor interaction.
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Detection of Glycoprotein of
Burkholderia pseudomallei
To the Editor: Melioidosis, a potentially fatal
disease that is difficult to diagnose and treat, is
common in areas with subtropical climate (e.g.,
Singapore, the southern provinces of China) and
is hyperendemic in Thailand. The etiologic agent,
Burkholderia pseudomallei ( Pseudomonas
pseudomallei), is widely distributed in Southeast
Asia and northern Australia. The agent has the
potential to become established in regions with
similar climate conditions, particularly if ani-
mals infected with B. pseudomallei are imported
from endemic-disease zones (1-3).
Rapid and reliable detection of B. pseudomallei
and its antigens has many potential applications.
Recently, we developed a monoclonal antibody
immunoenzyme test system for the detection of
minimal concentrations of a B. pseudomallei
glycoprotein, which is considered one of the
pathogenicity factors for this microorganism.
This glycoprotein, called Ag8 by N.N. Piven and
V.I. Ilyukhin (4), is present in different strains of
B. pseudomallei and B. mallei but not in other
Burkholderia spp. (B. aeruginosa, B. putida, B.
cepacia, B. malthophilia, B. fluorescens, B.
pseudoalcaligenes). Ag8 is composed of 10% protein
and 90% carbohydrate, has molecular mass 800
kDa, and is localized in an extracellular capsulelike
substance surrounding B. pseudomallei cells (5).
We developed an immunoenzyme test system
with three monoclonal antibodies (Mab) to
different epitopes of Ag8 (Mab 2A6-IgG3, Mab
2H7-IgG1, Mab 1G2-IgG2b) and one antibody to
epitopes common for Ag8 and LPS of B.
pseudomallei (mab 1ES-IgG2b). A sandwich
enzyme-linked immunosorbent assay (ELISA) was
used for the detection of Ag8 in different test
samples (6). The sensitivity of the immunoenzyme
test system was determined with a standard
antigen sample. Minimal sensitivity (37 ng/ml of
carbohydrate) was observed when polyclonal
immunoglobulins were used as “catching” antibod-
ies. Maximal sensitivity (0.37 ng/ml of carbohy-
drate) was noted when either Mabs 2A6 or mixtures
of Mabs were used as catching antibodies.
The test system was further evaluated with
samples of extracellular antigens (extracts of
cultural media, fractions after gel chromatogra-
phy of extracellular antigens) and bacterial
suspensions of B. pseudomallei and B. mallei
strains isolated in different regions of the world.